Orexin Signaling, Glymphatic Clearance, and Preclinical Alzheimer's Disease: A Scoping Review and Hypothesis-Generating Conceptual Framework.
Current evidence for disease-modifying effects in humans is very limited and uncertain, and Mechanistic proof-of-concept studies must precede any consideration of larger trials or translational application.